Clinical Trials Logo

Severe Obesity clinical trials

View clinical trials related to Severe Obesity.

Filter by:
  • Active, not recruiting  
  • Page 1

NCT ID: NCT04165694 Active, not recruiting - Clinical trials for Bariatric Surgery Candidate

Single Anastomosis Duodenal Ileal Bypass (SADI) for Sleeve Revision

SADI
Start date: October 15, 2019
Phase: N/A
Study type: Interventional

The goal of this study is two part: 1) to add to the literature which is still somewhat sparse with numbers of patients undergoing the Single Anastomosis Duodenal Ileal Bypass (SADI) as a revision for laparoscopic sleeve gastrectomy (LSG) and 2) to have a treatment option for our Kaiser Permanente patients who seek additional assistance after a LSG with persistent morbid obesity and the comorbidities that come with it.

NCT ID: NCT03249441 Active, not recruiting - Severe Obesity Clinical Trials

Compassion-Focused Therapy for People With Severe Obesity.

CFT
Start date: September 15, 2016
Phase: N/A
Study type: Interventional

This study aims to explore the effectiveness of a group psychotherapy intervention using Compassion-Focused Therapy (CFT) in adults with severe obesity. In particular, it aims to evaluate the principle that CFT can be used to reduce levels of shame and self-criticism in adults with severe obesity OBJECTIVES: The objective of the current study is to assess and compare a CFT group intervention to Treatment as Usual (TAU) with regard to psychological functioning, specifically self-compassion, shame, self-criticism, emotional eating and mood.

NCT ID: NCT02767505 Active, not recruiting - Severe Obesity Clinical Trials

Bypass Equipoise Sleeve Trial (BEST)

BEST
Start date: September 2015
Phase: N/A
Study type: Interventional

This is nationwide registry-based randomised clinical multicenter trial in which patients will be randomised to gastric bypass (RYGB) or sleeve gastrectomy (SG). The co-primary endpoint are weight control over 5 years and the amount of severe adverse events. Additionally the investigators have predefined a number of secondary endpoints, and the trial has a sufficient number of patients to allow comparisons across subgroups.

NCT ID: NCT02374632 Active, not recruiting - Severe Obesity Clinical Trials

Gut Hormones as Mediators of Different Weight Loss Responses After Roux-en-Y Gastric Bypass

Start date: October 2014
Phase: Phase 4
Study type: Interventional

After gastric bypass, 10-20% of patients will obtain a suboptimal weight loss, often defined as <50% of the excess body weight. Exaggerated meal related secretion of gut hormones seem important for appetite reduction and subsequent weight loss after gastric bypass, however it is not clear whether different gut hormone responses are responsible for different postoperative weight loss responses. The purpose of the study is to investigate gut hormone secretion, vagal integrity and the effect of octreotide on ad libitum food intake in patients with suboptimal weight loss after gastric bypass and compare results to a matched group of gastric bypass operated patients with high postoperative weight loss but similar age, sex and preoperative BMI.

NCT ID: NCT02128802 Active, not recruiting - Renal Failure Clinical Trials

Obesity Surgery and Kidney Transplant for Patients With Obesity and Renal Failure

Start date: April 2014
Phase: N/A
Study type: Interventional

Gastric Bypass followed by renal transplantation is superior to medical management followed by renal transplant for patients with severe obesity and renal failure.